Ireland has reached a milestone in the governance of healthcare technology. The Health Information and Quality Authority has published the first national guidance for the responsible and safe use of artificial intelligence in health and social care services, commissioned by the Department of Health and released on 29 July 2026. The guidance arrives as AI is already being deployed across Irish health services, in radiology where it enables faster CT reading and flags abnormalities for clinical review, in consultation settings where it assists with clinical note-taking, and in administrative functions that free clinical staff for patient-facing work. HIQA's Director of Health Information and Standards Rachel Flynn confirmed that the guidance provides practical direction to harness these opportunities while ensuring that patient safety, transparency, and accountability remain at the forefront of every deployment decision. For health and safety professionals, quality managers, and clinical governance leads across Ireland's health and social care system, this is not a regulatory constraint. It is a safety framework that makes responsible AI adoption more confident, more defensible, and more consistent.

The guidance's central principle is one that health and safety professionals will recognise immediately: accountability must be established before deployment, not after. HIQA states explicitly that the person who deploys and uses an AI system is responsible for understanding how it operates within their service and for ensuring it delivers safe outcomes for patients. That principle mirrors the duty of care framework that underpins occupational health and safety governance across every regulated sector in Ireland, and its application to AI represents a significant and positive maturation of how healthcare organisations are expected to manage safety innovation. Clear lines of accountability, robust governance structures, and person-centred care are not new concepts in Irish health regulation. HIQA's guidance applies them to a new and rapidly evolving technology context with the same rigour that the Safety, Health and Welfare at Work Act 2005 applies to physical workplace risk.

The legislative backdrop reinforces the guidance's authority. Ireland's Regulation of Artificial Intelligence Bill 2026, which passed through the Seanad on 15 July 2026, establishes the AI Office of Ireland and implements the EU AI Act at national level, designating competent authorities and creating the regulatory infrastructure within which HIQA's health-specific guidance now sits. The EU AI Act classifies AI systems used in healthcare, including diagnostic support tools and clinical decision-making aids, as high-risk systems subject to the most rigorous conformity assessment requirements. HIQA's national guidance translates those requirements into practical implementation direction for Irish health and social care providers, giving organisations a clear, authoritative reference point for procurement, deployment, and ongoing safety management of AI tools that complements rather than duplicates existing regulatory obligations.

Three actions allow healthcare organisations and health and safety leaders to build confidently on HIQA's framework. First, every health and social care organisation deploying or planning to deploy AI systems should conduct an AI-specific risk assessment aligned to HIQA's national guidance, mapping each deployed system against the EU AI Act's risk classification tiers and establishing named accountability for governance, performance monitoring, and incident reporting before any clinical or administrative deployment proceeds. Second, health and safety management systems across hospital, community care, and social care settings should be updated to incorporate AI tool oversight as a formal governance category, treating AI-related adverse events with the same structured incident review and learning process applied to physical workplace safety incidents, ensuring that safety culture extends consistently into digital and algorithmic decision-making environments. Third, procurement leads and clinical governance teams should use the HIQA guidance as a specification framework in AI procurement processes, requiring suppliers to demonstrate conformity with EU AI Act obligations and HIQA's transparency and accountability standards as a condition of contract award rather than a post-deployment assessment.

Ireland's approach to AI in healthcare, anchored by HIQA's guidance, the Regulation of Artificial Intelligence Bill 2026, and the EU AI Act, gives the health and social care system a proactive safety infrastructure that many comparable systems are still building. The foundation is in place. The opportunity now is to deploy it with the same care and governance discipline that the guidance itself demands.